Literature DB >> 22910029

A potential role of progestin-induced laminin-5/α6-integrin signaling in the formation of side branches in the mammary gland.

Gabriele Meyer1, Jeffrey Leipprandt, Jianwei Xie, Mark D Aupperlee, Sandra Z Haslam.   

Abstract

Mammary organoids from adult mice produce tubules, analogous to mammary ducts in vivo, in response to hepatocyte growth factor (HGF) when cultured in collagen gels. The combination of HGF plus progestin (R5020) causes reduced tubule number and length. We hypothesized that the inhibitory effect on tubulogenesis was due to progestin-mediated alteration of HGF/c-Met signaling. Using molecular inhibitors and short hairpin RNA, it was determined that HGF activation of Ras-related C3 botulinum toxin substrate (Rac1) was required for the formation of cytoplasmic extensions, the first step of tubulogenesis, and that Rac1 activity was Src kinase (Src) and focal adhesion kinase (FAK) dependent. The highly novel finding was that R5020 reduced tubulogenesis by up-regulating and increasing extracellular laminin and α6-integrin ligation to reduce activation of the Src, focal adhesion kinase, and Rac1 pathway. Receptor activator of nuclear factor-κB ligand, another progesterone-induced paracrine factor, did not replicate this effect of R5020. The inhibitory effect of R5020 on tubulogenesis was likely mediated through progesterone receptor (PR) isoform A (PRA), because PRA is the predominant PR isoform expressed in the organoids, and the progestin-induced effect was prevented by the PR antagonist RU486. These results provide a plausible mechanism that explains progestin/PRA-mediated blunting of HGF-induced tubulogenesis in vitro and is proposed to be relevant to progesterone/PRA-induced side-branching in vivo during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22910029      PMCID: PMC3512027          DOI: 10.1210/en.2012-1518

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  42 in total

1.  The Rho family of small GTPases is involved in epithelial cystogenesis and tubulogenesis.

Authors:  Katherine K Rogers; Tzuu-Shuh Jou; Wei Guo; Joshua H Lipschutz
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

2.  Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures.

Authors:  Celeste M Nelson; Martijn M Vanduijn; Jamie L Inman; Daniel A Fletcher; Mina J Bissell
Journal:  Science       Date:  2006-10-13       Impact factor: 47.728

3.  Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling.

Authors:  C Brisken; A Heineman; T Chavarria; B Elenbaas; J Tan; S K Dey; J A McMahon; A P McMahon; R A Weinberg
Journal:  Genes Dev       Date:  2000-03-15       Impact factor: 11.361

4.  IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development.

Authors:  Y Cao; G Bonizzi; T N Seagroves; F R Greten; R Johnson; E V Schmidt; M Karin
Journal:  Cell       Date:  2001-12-14       Impact factor: 41.582

5.  Hepatocyte growth factor switches orientation of polarity and mode of movement during morphogenesis of multicellular epithelial structures.

Authors:  Wei Yu; Lucy E O'Brien; Fei Wang; Henry Bourne; Keith E Mostov; Mirjam M P Zegers
Journal:  Mol Biol Cell       Date:  2003-02       Impact factor: 4.138

6.  Hepatocyte growth factor is required for progestin-induced epithelial cell proliferation and alveolar-like morphogenesis in serum-free culture of normal mammary epithelial cells.

Authors:  N Sunil; Jessica M Bennett; Sandra Z Haslam
Journal:  Endocrinology       Date:  2002-08       Impact factor: 4.736

7.  Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform.

Authors:  Biserka Mulac-Jericevic; John P Lydon; Francesco J DeMayo; Orla M Conneely
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-01       Impact factor: 11.205

8.  Microscopic analysis of the cellular events during scatter factor/hepatocyte growth factor-induced epithelial tubulogenesis.

Authors:  M J Williams; P Clark
Journal:  J Anat       Date:  2003-11       Impact factor: 2.610

9.  Estrogen mediates mammary epithelial cell proliferation in serum-free culture indirectly via mammary stroma-derived hepatocyte growth factor.

Authors:  Hong-Zheng Zhang; Jessica M Bennett; Kyle T Smith; Nityanand Sunil; Sandra Z Haslam
Journal:  Endocrinology       Date:  2002-09       Impact factor: 4.736

10.  GDNF promotes tubulogenesis of GFRalpha1-expressing MDCK cells by Src-mediated phosphorylation of Met receptor tyrosine kinase.

Authors:  Anna Popsueva; Dmitry Poteryaev; Elena Arighi; Xiaojuan Meng; Alexandre Angers-Loustau; David Kaplan; Mart Saarma; Hannu Sariola
Journal:  J Cell Biol       Date:  2003-04-07       Impact factor: 10.539

View more
  6 in total

1.  Progesterone stimulates proliferation and promotes cytoplasmic localization of the cell cycle inhibitor p27 in steroid receptor positive breast cancers.

Authors:  Anastasia Kariagina; Jianwei Xie; Ingeborg M Langohr; Razvan C Opreanu; Marc D Basson; Sandra Z Haslam
Journal:  Horm Cancer       Date:  2013-08-31       Impact factor: 3.869

2.  Progesterone decreases levels of the adhesion protein E-cadherin and promotes invasiveness of steroid receptor positive breast cancers.

Authors:  Anastasia Kariagina; Jianwei Xie; Ingeborg M Langohr; Razvan C Opreanu; Marc D Basson; Sandra Z Haslam
Journal:  Horm Cancer       Date:  2013-08-31       Impact factor: 3.869

3.  Research resource: progesterone receptor targetome underlying mammary gland branching morphogenesis.

Authors:  Ashlee R Lain; Chad J Creighton; Orla M Conneely
Journal:  Mol Endocrinol       Date:  2013-08-26

4.  Hormonal regulation of epithelial organization in a three-dimensional breast tissue culture model.

Authors:  Lucia Speroni; Gregory S Whitt; Joanna Xylas; Kyle P Quinn; Adeline Jondeau-Cabaton; Clifford Barnes; Irene Georgakoudi; Carlos Sonnenschein; Ana M Soto
Journal:  Tissue Eng Part C Methods       Date:  2013-06-25       Impact factor: 3.056

5.  Systems pharmacology of mifepristone (RU486) reveals its 47 hub targets and network: comprehensive analysis and pharmacological focus on FAK-Src-Paxillin complex.

Authors:  Suhong Yu; Xingtian Yang; Yewei Zhu; Fangwei Xie; Yusheng Lu; Ting Yu; Cuicui Yan; Jingwei Shao; Yu Gao; Fan Mo; Guoneng Cai; Patrick J Sinko; Lee Jia
Journal:  Sci Rep       Date:  2015-01-19       Impact factor: 4.379

6.  Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ.

Authors:  Patricia Casbas-Hernandez; Monica D'Arcy; Erick Roman-Perez; Heather Ann Brauer; Kirk McNaughton; Samantha M Miller; Raghav K Chhetri; Amy L Oldenburg; Jodie M Fleming; Keith D Amos; Liza Makowski; Melissa A Troester
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.